fda approval for semaglutide 🎉Exciting news that is now approved MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Novo Nordisk's Ozempic® pill, the

The proven ability of GLP-1s to lower HbA1c with a low risk of hypoglycemia has now skyrocketed their adoption

GLP-1 drugs and their labeling and regulatory history relevant to NAION

HengenMLonsdorfer-WolfEvelyneECharlesA-LMasatJ.Reduced exercise capacity in patients with fibromyalgia: central or peripheral mechanisms

You would need to have a consultation with one of our Nurse Practitioners about your medical condition to make sure you are safe to begin taking semalutide before obtaining a prescription

Eric Topol, MDs Post The expansion of GLP-1 drug efficacy evidence in 2024, a concise review by Daniel Drucker, a pioneer of the field GLP1 medications are extremely valuable in diabetes and some obesity indications